Andreas Kaiser

Andreas Kaiser has extensive work experience in the field of biotechnology and quality management. Andreas currently serves as the Quality Manager at NEOGAP Therapeutics AB, where they are responsible for establishing and managing a Quality Management System for the production of personalized raw materials used in the manufacturing of Advanced Therapy Medicinal Products. Prior to this role, Andreas worked as a Principal Scientist at TCER AB (now NEOGAP Therapeutics AB), where they developed and optimized manufacturing processes and established a Quality Management System for the production of raw materials under Good Manufacturing Practice.

Before their time at TCER AB, Andreas worked as a Research Coordinator at Karolinska Institutet and as a Researcher at KTH. At KTH, they focused on developing a sensor system for circulating tumor cells. Andreas also worked as a Senior Scientist at LingVitae AB, managing interdisciplinary R&D projects involving optical disk platforms for immunodiagnostic assays and DNA sequencing. Additionally, Andreas served as a Senior Development Engineer at Attana AB, where they developed surface coatings for sensor chips used in molecular interaction studies.

Andreas began their career as a PhD student at Linköping University, conducting research on biochips and surface coatings. Andreas also worked as a Development Engineer at Biosensor Applications AB, contributing to the development of biosensor systems for the detection of narcotics and explosives. Early in their career, Andreas served as a Bacteriologist at the Central Science Laboratory.

Overall, Andreas Kaiser's work experience demonstrates their expertise in quality management, manufacturing processes, sensor systems, and biochips.

Andreas Kaiser attended Linköping University from 1996 to 2002, where they earned a MSE degree in Engineering Biology.